- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Lumisys turns profit despite dip in revenues
Lumisys turns profit despite dip in revenuesRevenues at Lumisys declined 24% during the company's second quarter. For the period (end-June), revenues were $5.4 million, compared with $7.2 million last year. The firm did post a profit of $62,000,
Lumisys turns profit despite dip in revenues
Revenues at Lumisys declined 24% during the company's second quarter. For the period (end-June), revenues were $5.4 million, compared with $7.2 million last year. The firm did post a profit of $62,000, however, compared with a net loss of $141,000 in 1997. Company executives believe the financial performance will improve going forward.
In other news, Lumisys has completed a beta test for its ACR-2000 CR system (PNN 6/98)
- Search again
- Homepage
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
